3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Genitourinary
1
Conditions
Prostatic Neoplasms
3
Neoplasms
2
Salivary Gland Adenoma, Pleomorphic
1
Prostatic Hyperplasia
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Acute Kidney Injury
1
Interventions
Blood Specimen Collection
38
pembrolizumab
36
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
18
Exercise
17
Carboplatin
16
Nivolumab
15
atezolizumab
14
Cisplatin
14
Drug Therapy
13
Paclitaxel
12
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
12
Trastuzumab
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Pemetrexed
9
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Urination
×
Clear all
NCT04691284
2025-05-29
SCTMICROBIOM
National Cancer Institute, Slovakia
Phase NA
Recruiting
100 enrolled
NCT04442516
2024-04-17
ACCENT
The Hospital for Sick Children
Recruiting
600 enrolled